Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1878-7479
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease ; day:30 ; month:5 ; year:2017 ; pages:1-15
Neurotherapeutics ; (30.5.2017), 1-15
- Schlagwort
-
Gehirn
Zentralnervensystem
- Urheber
-
Haberman, Rebecca P.
- Beteiligte Personen und Organisationen
-
Branch, Audrey
Gallagher, Michela
SpringerLink (Online service)
- DOI
-
10.1007/s13311-017-0541-z
- URN
-
urn:nbn:de:1111-201706236785
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Haberman, Rebecca P.
- Branch, Audrey
- Gallagher, Michela
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease